![](https://medcitynews.com/wp-content/uploads/sites/7/2019/01/FDAmed.jpg)
FDA Approval of Alopecia Drug Positions Sun Pharma to Compete With Eli Lilly, Pfizer
Hair loss caused by alopecia areata now has a new FDA-approved treatment, a third-in-class drug from Sun Pharmaceutical Industries that will compete against commercialized medicines from Eli Lilly and Pfizer. The regulatory decision announced Friday for …